Image optimize LCP
  • Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • Maternova is a mission-driven corporation focused on women and newborn health.


    Our social enterprise has impacted over 2.1 million lives since 2015.

    2.1 million

    Women and Infants

    180+

    Countries

    30.000

    Clinicians

    30

    SME partners

    Thumbnail for Maternova video, includes women, children and doctors

    Problems We Focus On

    STIs and HIV: Women and Children

    Embark on a Path of Hope: Maternova's Lifesaving Solutions for Women and Children

    Learn more

    Women's Reproductive Health

    Experience the Cutting-Edge Bouquet Speculum:
    Advancing Women's Reproductive Well-being.

    Learn more

    As seen in ...

    Cartier Women's Initiative Awards Logo

    Work with us

    Listen to our customers

    Our Trusted Partners

    logo-1
    logo-2
    logo-3
    logo-4
    logo-5
    logo-6
    logo-7
    logo-8
    logo-9
    The novel vital signs alert built into the CRADLE for eclampsia and shock detection

    The novel vital signs alert built into the CRADLE for eclampsia and shock detection

    2 lire la lecture

    The CRADLE Vital Signs Alert is an innovative semi-automatic device for midwifery and obstetrics.  The device takes blood pressure and heart rate and then calculates shock index, making the whole process semi-automatic. 
    NASG or TANN for postpartum hemorrhage CE-marked device

    Comment fonctionne réellement le NASG pour arrêter l’hémorragie et inverser le choc ?

    2 lire la lecture

    Le TANN (en espagnol) ou NASG est un dispositif de premiers secours obstétricaux. Il s'agit d'une grosse boule de mousse dense cousue solidement dans un rectangle de mousse, le tout conçu pour être bien ajusté autour de l'utérus et serré avec du velcro cousu.
    The bubble CPAP reducing neonatal mortality by 27 percent

    La CPAP à bulles réduit la mortalité néonatale de 27 %

    2 lire la lecture

    Expérience nigériane avec un projet pilote dans 7 hôpitaux utilisant le CPAP à bulles.